Equity
AOCI
Revolution Medicines, Inc. AOCI decreased by 119.2% to -$622.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 136.4%, from $1.71M to -$622.00K. Over 5 years (FY 2020 to FY 2025), AOCI shows an upward trend with a 94.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2019
Last reportedQ1 2026May 6, 2026
How to read this metric
Fluctuations often signal changes in foreign exchange rates, interest rate environments, or pension funding status.
Detailed definition
Accumulated Other Comprehensive Income (AOCI) captures the cumulative unrealized gains and losses that are excluded from...
Peer comparison
Standard equity component for large multinational corporations with complex balance sheets.
Metric ID:
aociHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.00K | -$40.00K | -$376.00K | -$1.28M | -$1.77M | -$2.42M | -$1.78M | -$556.00K | -$1.25M | -$871.00K | $544.00K | -$1.20M | -$1.86M | $3.81M | $1.32M | $1.71M | $1.30M | $3.12M | $3.24M | -$622.00K |
| QoQ Change | — | -544.4% | -840.0% | -241.5% | -37.5% | -37.1% | +26.4% | +68.8% | -125.0% | +30.4% | +162.5% | -320.2% | -55.5% | +304.6% | -65.3% | +29.2% | -23.7% | +139.3% | +3.9% | -119.2% |
| YoY Change | — | — | — | — | <-999% | <-999% | -373.4% | +56.7% | +29.1% | +64.0% | +130.6% | -115.5% | -48.9% | +537.7% | +142.8% | +242.5% | +169.9% | -18.3% | +145.0% | -136.4% |
Range-$2.42M – $3.81M
CAGR+143.9%
Avg YoY Growth<-999%
Median YoY Growth+42.9%
AOCI at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s aoci?
- Revolution Medicines, Inc. (RVMD) reported aoci of -$622.00K in Q1 2026.
- How has Revolution Medicines, Inc.'s aoci changed year-over-year?
- Revolution Medicines, Inc.'s aoci decreased by 136.4% year-over-year, from $1.71M to -$622.00K.
- What is the long-term trend for Revolution Medicines, Inc.'s aoci?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s aoci has grown at a 94.6% compound annual growth rate (CAGR), from $116.00K to $3.24M.
- What does aoci mean?
- The cumulative total of unrealized gains and losses not yet reflected in net income.